The Technical Analyst
Select Language :
XTL Biopharmaceuticals [XTLB]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology

XTL Biopharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

XTL Biopharmaceuticals is listed at the NASDAQ Exchange

4.07% $2.81

/ 28 mar 2024 @ 16:00


XTL Biopharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 17.90 mill
EPS: -0.400
P/E: -7.02
Earnings Date: Mar 14, 2024
SharesOutstanding: 6.37 mill
Avg Daily Volume: 0.738 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -7.02 | sector: PE 0
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -7.02 | industry: PE 0
DISCOUNTED CASH FLOW VALUE
$0.0093
(-99.67%) $-2.80
Date: 2024-03-28
Expected Trading Range (DAY)

$ 2.76 - 2.86

( +/- 1.67%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2008-11-18 Edelman Joseph Sell 24 681 360 Ordinary Shares
2008-11-18 Edelman Joseph Sell 2 696 450 Ordinary Shares
2008-11-19 Edelman Joseph Sell 9 600 000 Ordinary Shares
2008-11-18 Edelman Joseph Sell 29 740 Ordinary Shares
2008-11-18 Edelman Joseph Sell 400 000 Ordinary Shares
INSIDER POWER
0.00
Last 100 transactions
Buy: 14 134 720 | Sell: 44 453 703

Forecast: 16:00 - $2.83

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.83
Forecast 2: 16:00 - $2.83
Forecast 3: 16:00 - $2.83
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.81 (4.07% )
Volume 0.233 mill
Avg. Vol. 0.738 mill
% of Avg. Vol 31.53 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for XTL Biopharmaceuticals Ltd.

Last 12 Months

Last 12 months chart data with high, low, open and close for XTL Biopharmaceuticals Ltd.

RSI

Intraday RSI14 chart for XTL Biopharmaceuticals Ltd.

Last 10 Buy & Sell Signals For XTLB

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            XTL Biopharmaceuticals Ltd.

XTLB

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

Last 10 Buy Signals

Date Signal @
MNTUSDMar 28 - 18:071.210
KDAUSDMar 28 - 18:06$1.470
KASUSDMar 28 - 18:060.139
HUNTUSDMar 28 - 18:050.513
HBARUSDMar 28 - 18:07$0.116
BELUSDMar 28 - 18:070.967
BNTUSDMar 28 - 18:07$0.881
BNBUSDMar 28 - 18:06$580.45
ABTUSDMar 28 - 18:052.04
WAVESUSDMar 28 - 18:04$3.93

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.